Behind the Breakthrough: Patent FAQ

Behind the Breakthrough: Patent FAQ 1. What was just announced?Dr. Shai Berlin, an NMDA receptor expert part of a collaborative network of laboratories supported by the 2BCured Foundation, made an important scientific breakthrough relating to GRIN2B-Related Neurodevelopmental Disorder resulting in the issuance of a patent. 2. How does the therapy work? The therapy uses a […]

Innovation in Motion: GRIN2B Patent Marks Key Advancement

Innovation in Motion: GRIN2B Patent Marks Key Advancement Professor Shai Berlin, a lead scientist with the 2BCured research team, announced the issuance of a patent for a novel gene therapy aimed at treating GRIN2B-Related Neurodevelopmental Disorder. The patent involves use of a recombinant adeno-associated virus (AAV) vector capable of delivering a full-length, healthy GRIN2B gene […]